Background: Sarcoidosis is a granulomatous disease characterized by the accumulation of activated T cells in the lungs. We previously showed that sarcoidosis patients expressing the HLA haplotype DR3(17),DQ2 had increased numbers of lung CD4+ T cells using the T cell receptor (TCR) variable region (V) a 2.3 gene segment product. In the present study, the composition of both the TCR a-and (3-chains of the expanded CD4+ lung T cells from four DR3(17),DQ2+ sarcoidosis patients was
INTRODUCTION
Sarcoidosis is characterized by the formation of non-caseating granulomas in affected organs, de-288 Molecular Medicine, Volume 1, Number 3, March 1995 pathogenesis of sarcoidosis (2, 3) . In order to specifically identify an antigen, T cells need to have the antigen presented as peptides in the context of the major histocompatibility complex (MHC) (in humans called HLA) molecules (4) . Most T lymphocytes use aoj T cell receptor (TCR), con- sisting of a and f3 polypeptide chains for antigen recognition. Each chain is composed of a constant and a variable part, the latter made up of random combinations of V (variable), D (diversity; only the 1-chain) and J (joining) gene segments (5) . T cells with preferential use of particular TCR V genes have been described in several human diseases, such as multiple sclerosis (6) , rheumatoid arthritis (7, 8) and inflammatory vascular diseases (9, 10) . If T cells with restricted TCR V gene usage prove to be important for the development of the disease, a highly selective type of immune intervention may be undertaken (6) . In animal models, it has been possible to selectively manipulate T cells with a restricted TCR V gene usage to succesfully prevent and modulate disease (1, 12) .
In sarcoidosis, several groups have shown a preferential TCR V gene usage by lung T cells and have suggested that there is a specific sarcoidosisassociated antigen in the lungs of these patients (13) (14) (15) (16) (17) (18) (19) (20) (21) (19, 20) . In the present study, a more extensive analysis of the TCR expressed by these CD4+ GCTCCTGGACCCTTCAATGTTCC-3'), including a Sph I cleavage site at the 5' end (underlined), in combination with a C,-antisense primer (5'-GGGTCGACTAGGCAGACAGACTTGTCACT -3') with a Sal I cleavage site (underlined). The PCR profile used was the following: 94°C (60 sec), 55°C (60 sec) and 72°C (60 sec) for 38 cycles, with a final extension of 5 min. After PCR amplification, PCR products were cleaved with Sal I/Sph I and loaded on a low melting agarose gel. DNA bands corresponding to 500 bp were subsequently cut out from the gel, purified using Geneclean kit (Bio 101, La Jolla, CA, U.S.A.) and ligated into a Sal I/Sph I-cleaved pUC 18 plasmid. Alternatively, PCR fragments amplified using primers without restriction enzyme cleavage sites were inserted blunt ended into a linearized pUC18 plasmid. The vector was inserted into competent Escherichia coli (JM 105) and grown on ampicillin/streptomycin plates. Positive colonies were picked using blue/white selection, and further PCR amplified and biotin labeled using pUC18 primers as described (26) .
DNA Sequencing
Amplified biotin-labeled clones were subjected to solid-phase sequencing as described (27, 28) . Briefly, the PCR mixture was immobilized on streptavidin coupled magnetic beads (Dynabeads; Dynal, Oslo, Norway). After washing and denaturation, single-stranded DNA was eluted and subsequently neutralized. Sequencing reactions were performed using AutoRed T7 sequencing kit (Pharmacia, Uppsala, Sweden) in a robot workstation (Biomek-1000; Beckman, Palo Alto, CA, U.S.A.). Samples were loaded on a sequencer (Pharmacia) with detection of fluorescent bands during electrophoresis. (25) . After washing the filters, they were exposed to Hyperfilm MP (Amersham) overnight at -70°C. Gel scanning technique (2400 GelScan XL; Pharmacia-LKB) was used for quantification of exposed films.
Analysis of Jo Gene Segment Usage VP 7-, VP 12-, VP 13.1-, and VP 18-amplified PCR products of Patient 2 were transferred to Hybond-N nylon filters, using a Bio-Dot SF microfiltration unit (Bio-Rad, Hercules, CA, U.S.A.). Filters were then treated as above, and hybridizations were performed overnight using 5'-(-y-32P) -ATP end-labeled JP-specific oligonucleotide probes. Washing, film-exposure, and gel scanning (for quantification) were performed as described above and in detail in Ref. 22 
DISCUSSION
The previously described absolute positive correlation between lung restricted Va 2.3+ CD4+ T cell expansions and expression of HLA-DR3(17),DQ2 in sarcoidosis patients with clinical disease, prompted us to suggest the presence of a specific sarcoidosis-associated antigen in the lungs of these (HLA-DR3+) sarcoidosis patients (19, 20) . In order to understand more about these lung accumulated Va 2.3+ CD4+ T cells, presumably reacting to a specific antigen, we have analyzed the composition of the rest of the TCR molecules expressed by these cells.
Use of Ja segments by the a-chains of V. a2 + 4 of the amino acid sequences were identical (see Table 2 ).
b5 of the amino acid sequences were identical (see Table 3 ). 
3 + 2.14 + 1.10 5'-TGT GTG GTG GAT TAT GGA GGA AGC CAA GGA AAT 2. 30 5'-TGT GTG GTG -GAT TAC GGA GGA AGC CAA GGA AAT 2.43 5'-TGT GTG GTG -GAT TAC GGA GGA AGC CAG GGA AAT
5'-TGT GTG GTC -CCA TCA GGA GGA AGC CAA GGA AAT 2.37 5'-TGT GTG GTC -CCA TCA GGA GGG AGC CAA GGA AAT Nucleotides that alter between sequences are underlined. The identical sequences 2.3/2.14 and 1.10 are from two different patients (Patients 2 and 1, respectively) . Note that the tyrosine (Y) at the second 5' position of Ja 9.11, in the upper group of sequences, is substituted with a serine (S), with similar properties, in sequences 2. 8 (31, 32) . In sarcoidosis, the onset of disease in the majority of patients is insidious, making it difficult to evaluate any possible influence of disease duration. The genetic background of the individuals may also influence TCR V gene usage in health (33, 34) , as well as in disease (21) .
In addition to HLA-DR3+, other HLA alleles, as well as other genes such as the Tap-genes (35), may be important here. Finally, although expanded lung T cells used a particular Va gene and were strictly CD4+, oligoclonal to some degree, and seemingly restricted by HLA-haplotype, the possibility of a superantigen-driven T cell response in sarcoidosis cannot be completely excluded by the present results. It has recently been suggested that superantigens with a low affinity to its specific TCR V gene segment product would preferentially stimulate CD4+ cells, since these cells could, unlike CD8+ cells, strengthen the avidity to the MHC class II bearing superantigen presenting cell. Moreover, a bias in the usage of other TCR gene products, which would improve the binding to such antigen presenting cell, could also be expected (36) .
In conclusion, we have examined the detailed composition of the TCR a-and ,B-chains of expanded Va 2.3+ CD4+ lung T cells of HLA-DR3+ patients with pulmonary sarcoidosis. Evi- dence for a restricted a-chain usage was found, with convergence at the nucleotide level towards the same or similar amino acid sequences. On the other hand, the V, usage by the same cells was, with one exception, nonrestricted. These results indicate that oligoclonal T cells expand as a result of antigen recognition in the lungs of this group of sarcoidosis patients, with the TCR a-chain being the most important (T cell) component in such a specific interaction.
